Cost Effectiveness of Hormone Replacement Therapy in French Postmenopausal Women

  • Geneviève Plu-Bureau
  • Dominique Bureau
  • Jean-Christophe Thalabard
Conference paper


The beneficial effects of hormone replacement therapy (HRT) in preventing osteoporosis and, reportedly, ischemic heart disease gives support to its extension to symptom-free women. The purpose of our study is a reevaluation of the risks, benefits, and costs of HRT primary prevention in the French context. In addition to the methodology of benefit analysis, we used two methodological tools, Markovian cohort simulations and meta-analyses. We took into account potential long-term effects, and particularly possible increase in breast cancer risk. The life expectancy gain was evaluated to 0.16 year for a 10-year HRT duration, and the discounted cost/year gained from HRT is FF 143,000 (US $28,600). Our study led to an intermediate cost effectiveness ratio as compared with other accepted health care interventions. However, prevention might be cost effectiveness in specific subpopulations. The study underlines the lack of data about the net effect of combined HRT and the persistence of the effect of HRT after discontinuation.


Breast Cancer Risk Endometrial Cancer Hormone Replacement Therapy Methodological Tool Combine Confidence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bureau D, Plu-Bureau G, Thalabard JC (1993) L’évaluation des traitements médicaux: Méthodes et enjeux. Economie et Statistiques 6:65–75.CrossRefGoogle Scholar
  2. 2.
    Daly E, Roche M, Barlow D, et al. (1992) An analysis of benefits, risks and costs. Brit Med Bull 48:368–400.PubMedGoogle Scholar
  3. 3.
    Tosteson AN, Rosenthal DI, Melton J, et al. (1990) Cost effectiveness of screening preimenopausal white women for osteoporosis: Bone densitometry and hormone replacement therapy. Ann Int Med 113: 594–604.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • Geneviève Plu-Bureau
  • Dominique Bureau
  • Jean-Christophe Thalabard

There are no affiliations available

Personalised recommendations